Interleukin-6 Serum Levels in Patients with Parkinson’s Disease
✍ Scribed by Kerly Wollmeister Hofmann; Artur Francisco Schumacher Schuh; Jonas Saute; Raquel Townsend; Daniele Fricke; Renata Leke; Diogo O. Souza; Luis Valmor Portela; Márcia Lorena Fagundes Chaves; Carlos R. M. Rieder
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 188 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0364-3190
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Serum levels of IL‐6 were evaluated in a large group of patients with benign or malignant gynecological tumors. The results obtained were correlated with the patients' clinicopathological features and follow‐up data. Using a highly sensitive immunoenzymatic method for the evaluation of
## Abstract Expression of interleukin‐6 (IL‐6) and IL‐6 receptors has been demonstrated in Hodgkin and Reed‐Sternberg (H and RS) cells __in vitro__ and __in vivo__. In order to evaluate the clinical significance of IL‐6 serum levels in patients with Hodgkin's disease (HD), we tested the sera of 56